Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Vasculitis

  • PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

The primary systemic vasculitides in childhood are quite rare except for Henoch-Schönlein purpura and Kawasaki disease. These are usually self-limited diseases. The etiopathogenesis for most of them is not clearly understood. However, it is usually thought that environmental triggers (mostly infectious) evoke an aggravated inflammatory response in susceptible individuals. The classification criteria for most of them were recently validated for children. Clinical manifestations are determined by the organs affected, reflecting the involved vessels on a background of constitutional symptoms. For treatment, the main data are adapted from adult studies, especially for rarer vasculitides in childhood. In this review, the recent classification criteria, current pathophysiologic pathways, and treatment protocols are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Brogan PA, Dillon MJ. Vasculitis from the pediatric perspective. Curr Rheumatol Rep. 2000;2:411–6.

    Article  PubMed  CAS  Google Scholar 

  2. Rowley AH, Ozen S, Sundel RP, et al. A clinician’s pearls and myths in rheumatology. London: Springer; 2009. p. 219–29.

    Book  Google Scholar 

  3. Ozen S. Problems in classifying vasculitis in children. Pediatr Nephrol. 2005;20:1214–8.

    Article  PubMed  Google Scholar 

  4. Ruperto N, Ozen S, Pistorio A, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: overall methodology and clinical characterization. Ann Rheum Dis. 2010;69:790–7.

    Article  PubMed  Google Scholar 

  5. •• Ozen S, Pistoiro A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69:798–806. This is the criteria validation for most of the vasculitides in childhood.

    Article  PubMed  Google Scholar 

  6. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PRES endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–41.

    Article  PubMed  CAS  Google Scholar 

  7. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children. Am J Dis Child. 1960;99:833–54.

    CAS  Google Scholar 

  8. Gedalia A. Henoch-Schönlein purpura. Curr Rheumatol Rep. 2004;6:195–202.

    Article  PubMed  Google Scholar 

  9. Saulsbury FT. Epidemiology of Henoch-Schönlein purpura. Cleve Clin J Med. 2002;69:SII87–9.

    Article  PubMed  Google Scholar 

  10. Lau KK, Wyatt RJ, Moldoveanu Z, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol. 2007;22:2067–72.

    Article  PubMed  Google Scholar 

  11. Kawasaki Y, Suyama K, Yugeta E, et al. The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima prefecture, Japan. Int Urol Nephrol. 2010;42:1023–9.

    Article  PubMed  Google Scholar 

  12. Kawasaki Y. The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis. Clin Exp Nephrol 2011, In press.

  13. Shin JI, Song KS, Kim H, et al. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura. Br Assoc Dermatol. 2011;164:1348–55.

    Article  CAS  Google Scholar 

  14. Chen T, Guo Z-P, Li M-M, et al. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schönlein purpura. Clinical and Experimental Immunology 2011, In press.

  15. Brogan P, Bagga A. Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE, Laxer RM, et al., editors. Textbook of pediatric rheumatology. Philadelphia: Saunders Elsevier; 2011. p. 482–97.

    Google Scholar 

  16. Roberts PF, Waller TA, Brinker TM, et al. Henoch-Schönlein purpura: a review article. South Med J. 2007;100(8):821–4.

    Article  PubMed  Google Scholar 

  17. Chen S-Y, Kong M-S. Gastrointestinal manifestations and complications of Henoch-Schönlein purpura. Chang Gung Med. 2004;27:175–81.

    Google Scholar 

  18. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90:916–20.

    Article  PubMed  CAS  Google Scholar 

  19. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet. 2007;369(9566):976–8.

    Article  PubMed  Google Scholar 

  20. Rostoker G. Schönlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs. 2001;15(2):99–138.

    Article  PubMed  CAS  Google Scholar 

  21. Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol. 2002;16(3):411–25.

    PubMed  CAS  Google Scholar 

  22. •• Davin J-C. Henoch-Schönlein purpura nephritis: pathophysiology, treatment and future strategy. Clin J Am Soc Nephrol. 2011;6:679–89. This is an excellent review describing the treatment strategies on pathogenetic pathways in HSP.

    Article  PubMed  Google Scholar 

  23. Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol. 1998;49(1):9–14.

    PubMed  CAS  Google Scholar 

  24. Flynn JT, Smoyer WE, Bunchman TE, et al. Treatment of Henoch-Schönlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol. 2001;21:128–33.

    Article  PubMed  CAS  Google Scholar 

  25. Goldstein AR, White RHR, Akuse R, et al. Long term follow-up of childhood Henoch-Schönlein nephritis. Lancet. 1992;339:280–2.

    Article  PubMed  CAS  Google Scholar 

  26. Wakaki H, Ishikura K, Hataya H, et al. Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol. 2011;26:921–5.

    Article  PubMed  Google Scholar 

  27. Shulman ST, Rowley AH. Advances in Kawasaki disease. Eur J Pediatr. 2004;163:285–91.

    Article  PubMed  Google Scholar 

  28. De Rosa G, Pardeo M, Rigante D. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci. 2007;11:301–8.

    PubMed  Google Scholar 

  29. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708–33.

    Article  PubMed  Google Scholar 

  30. Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364:533–44.

    Article  PubMed  Google Scholar 

  31. Yanagawa H, Nakamura Y, Kawasaki T, et al. Nationwide epidemics of Kawasaki disease in Japan during winter of 1985–86. Lancet. 1986;2(8516):1138–9.

    Article  PubMed  CAS  Google Scholar 

  32. Burgner D, Davilla S, Breunis WB, et al. International Kawasaki Disease Genetic Consortium: a genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PloS Genet. 2009;5(1):e1000319.

    Article  PubMed  Google Scholar 

  33. Oh JH, Han JW, Lee SJ, et al. Polymorphisms of human leukocyte antigen genes in Korean children with Kawasaki disease. Pediatr Cardiol. 2008;29:402–8.

    Article  PubMed  Google Scholar 

  34. Hsieh Y-Y, Lin Y-J, Chang C-C, et al. Human lymphocyte antigen B-associated transcripts 2,3 and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm. J Clin Lab Anal. 2010;24:262–8.

    Article  PubMed  CAS  Google Scholar 

  35. Yeo Y, Kim T, Ha K, et al. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr. 2009;168:157–62.

    Article  PubMed  Google Scholar 

  36. Levy M, Karen G. Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J. 1990;9:122–6.

    Article  PubMed  CAS  Google Scholar 

  37. Pinna GS, Kafetzis DA, Tselkas OI, et al. Kawasaki disease: an overview. Curr Opin Infect Dis. 2008;21:263–70.

    Article  PubMed  Google Scholar 

  38. Galeotti C, Bayry J, Kone-Paut I, et al. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev. 2010;9:441–8.

    Article  PubMed  CAS  Google Scholar 

  39. •• Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol. 2011;In press. This is the most recent review defining clearly the challenges in KD.

  40. Tse SM, Silverman ED, Mc Crindle BW, et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr. 2002;140:450–5.

    Article  PubMed  CAS  Google Scholar 

  41. Sugahara Y, Ishii M, Muta H, et al. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29:398–401.

    Article  PubMed  Google Scholar 

  42. Furukawa T, Kishiro M, Akimoto M, et al. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child. 2008;93:142–6.

    Article  PubMed  CAS  Google Scholar 

  43. McCrindle BW. Kawasaki disease: a childhood disease with important consequences into adulthood. Circulation. 2009;120:6–8.

    Article  PubMed  Google Scholar 

  44. Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitis in Turkey: a nationwide survey. Clin Rheumatol. 2007;26:196–200.

    PubMed  Google Scholar 

  45. Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145:517–22.

    Article  PubMed  Google Scholar 

  46. Ozen S, Ben-Chetrit E, Bakkaloglu A, et al. Polyarteritis nodosa associated with familial mediterranean fever: is it an association? Semin Arthritis Rheu. 2001;30:281–7.

    Article  CAS  Google Scholar 

  47. Wright E, Dillon MJ, Tullus K. Childhood vasculitis and plasma exchange. Eur J Pediatr. 2007;166:145–51.

    Article  PubMed  Google Scholar 

  48. Schmidt WA. Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep. 2004;6:203–11.

    Article  PubMed  Google Scholar 

  49. Dillon MJ, Eleftherious D, Brogan PA. Medium-size-vessel vasculitis. Pediatr Nephrol. 2010;25:1641–52.

    Article  PubMed  Google Scholar 

  50. Dillon MJ. Vasculitis treatment: new therapeutic approaches. Eur J Pediatr. 2006;165:351–7.

    Article  PubMed  Google Scholar 

  51. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36–44.

    Article  PubMed  CAS  Google Scholar 

  52. Fernanda F, Serena C, Giustina R, et al. Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs. Rheumatol Int. 2011;In press.

  53. Fathalla BM, Miller L, Brady S, et al. Cutaneous polyarteritis nodosa in children. J Am Acad Dermatol. 2005;53:724–8.

    Article  PubMed  Google Scholar 

  54. David J, Ansell BM, Woo P. Polyarteritis nodosa associated with streptococcus. Arch Dis Child. 1993;69:685–8.

    Article  PubMed  CAS  Google Scholar 

  55. Radice A, Sinico RA. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity. 2005;38:93–103.

    Article  PubMed  CAS  Google Scholar 

  56. Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197–202.

    Article  PubMed  Google Scholar 

  57. Vamvakopoulos J, Savage CO, Harper L. ANCA-associated vasculitides—lessons from the adult literature. Pediatr Nephrol. 2010;25:1397–407.

    Article  PubMed  Google Scholar 

  58. Zwerina J, Eger G, Englbrecht M, et al. Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patient. Semin Arthritis Rheum. 2008;39:108–15.

    Article  PubMed  Google Scholar 

  59. Akikusa JD, Schneider R, Harvey EA, et al. Clinical features and outcome of pediatric Wegener’s granulomatosis. Arthritis & Rheumatism. 2007;52(5):837–44.

    Article  Google Scholar 

  60. Vanoni F, Bettinelli A, Keller F, et al. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol. 2010;25:205–12.

    Article  PubMed  Google Scholar 

  61. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.

    PubMed  CAS  Google Scholar 

  62. Sharma BK, Sagar S, Chugh KS, et al. Spectrum of renovascular hypertension in the young in north India. Angiology. 1985;36:370–8.

    Article  PubMed  CAS  Google Scholar 

  63. Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep. 2005;7:270–5.

    Article  PubMed  Google Scholar 

  64. Vanoli M, Daina E, Salvarini C, et al. Takayasu arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005;53:100–7.

    Article  PubMed  CAS  Google Scholar 

  65. Hahn D, Thomson PD, Kala U, et al. A review of Takayasu’s arteritis in children in Gauteng, South Africa. Pediatr Nephrology. 1998;12:668–75.

    Article  CAS  Google Scholar 

  66. •• Morishita KA, Rosendahl K, Brogan P. Familial Takayasu arteritis—a pediatric case and a review of the literature. Pediatr Rheum. 2011;In press. This is a recent review of familial TA cases in the literature encouraging the search for candidate genes in TA pathogenesis.

  67. Cakar N, Yalcinkaya F, Duzova A, et al. Takayasu arteritis in children. J Rheumatol. 2008;35:913–9.

    PubMed  Google Scholar 

  68. Yamada I, Nakagawa T, Himero Y, et al. Takayasu arteritis: diagnosis with breath hold contrast enhanced 3-dimensional MR angiography. J Magn Reson Imaging. 2000;II:481–7.

    Article  Google Scholar 

  69. Koening CL, Langford CA. Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am. 2006;32:173–86.

    Article  PubMed  Google Scholar 

  70. Ozen S, Duzova A, Bakkaloglu A, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007;150:72–6.

    Article  PubMed  CAS  Google Scholar 

  71. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;12:16–24.

    Article  Google Scholar 

  72. Lee GY, Jang SY, Ko SM, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol. 2011;In press.

  73. Ozen S. The ‘other’ vasculitic syndromes and kidney involvement. Pediatr Nephrol. 2010;25(9):1633–9.

    Article  PubMed  Google Scholar 

  74. Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behçet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58:3951–9.

    Article  PubMed  Google Scholar 

  75. Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–4.

    Article  PubMed  Google Scholar 

  76. •• Ozen S. Pediatric onset Behçet disease. Curr Opin Rheumatol. 2010;22:585–89. This is a recent review of childhood Behçet’s syndrome.

    Article  PubMed  Google Scholar 

  77. • Fei Y, Webb R, Cobb BL, et al. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther. 2009;11:R66. This was the first GWAS in Behçet’s syndrome.

    Article  PubMed  Google Scholar 

  78. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet. 2010;42(8):703–6.

    Article  PubMed  CAS  Google Scholar 

  79. International Study Group for Behcet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.

    Google Scholar 

  80. Hatemi G, Silman A, Bang D, et al. EULAR Expert Committee, EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656–62.

    Article  PubMed  CAS  Google Scholar 

  81. Cantarini L, Tinazzi I, Caramaschi P, et al. Safety and efficacy of etanercept in children with juvenile-onset Behcet’s disease. Int J Immunopathol Pharmacol. 2009;22:551–5.

    PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Hacettepe University Children’s Hospital, Sıhhiye, Ankara, 06100, Turkey

    Ezgi Deniz Batu

  2. Department of Pediatric Rheumatology, Hacettepe University, Sıhhiye, Ankara, 06100, Turkey

    Seza Ozen

Authors
  1. Ezgi Deniz Batu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seza Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seza Ozen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Batu, E.D., Ozen, S. Pediatric Vasculitis. Curr Rheumatol Rep 14, 121–129 (2012). https://doi.org/10.1007/s11926-011-0232-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-011-0232-4

Keywords

Search

Navigation